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ABSTRACT 
 
The pandemic of Acquired Immunodeficiency Syndrome (AIDS) continues to take a tragic toll on the lives of 
people in South East Asia, Africa and rest of the world. The most common cardiovascular findings are nonspecific 
ST and T wave changes dyslipidemia and Human Immunodeficiency Virus (HIV) associated cardiomyopathy. This 
continues to be even more prevalent as an adverse effect of the HAART therapy. The rationale of the present study 
was to assess the prevalence of lipid profile abnormalities in a study population of Jharkhand (Eastern India) done in 
Rajendra Institute of Medical Sciences (RIMS), Ranchi, at the Department of Medicine. The analysis revealed that 
the total cholesterol was significantly lower for the cases compared to the control group. HDL and LDL cholesterol 
were significantly lower, whereas TC/HDL was significantly higher. 60% of our patients were having a CD 4 count 
less than 200. The lower the CD 4 count higher was the chance for the patient to have an abnormal lipid profile. 
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Introduction 
 
 
Ever since it’s discovery in 1981,HIV/AIDS has grown 
into a disease of alarming proportions. Approximately 50 
million individuals are living with HIV/AIDS with an 
annual incidence of around 5 million. Slowly India is 
emerging as a nation with the largest number of people 
living with HIV/AIDS. HIV/AIDS is characterized by 
declining immunity. So these patients are predisposed to 
many opportunistic infections and malignancies that 
involve multiple systems. HIV infection is becoming one 
of the leading causes of acquired heart diseases and 
symptomatic heart failure. As therapy and longevity 
improve, cardiac complications of HIV are likely to 
become more prevalent in our society. A range of cardiac 
abnormalities has been suggested by autopsy studies 
which includes pericardial effusion, dilated 
cardiomyopathy and infective endocarditis[1,2]. Due to 
the prevalence of a different subtype [subtype – c] of HIV  
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and a unique population profile, any data on HIV 
infection from India is important. The present study 
involves evaluation of Lipid profile abnormalities in 
patients with HIV infection and is aimed at providing a 
baseline information in the study population involving 
patients from RIMS, Ranchi - Eastern India for the first 
time. 
 
Aim and objectives  
 
 To study the lipid profile abnormalities in HIV 
infected patient population in eastern india. 
 
Subject selection 
 
HIV positive patients including males and females 
admitted in the Department of Medicine, RIMS, 
Ranchi were selected for the study, after having met 
the inclusion and exclusion criteria. All participants 
were counselled  and an informed consent obtained. 
 
Inclusion criteria 
1. HIV positive patients within age group of 18 to 
60 years. 
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2. HIV infection confirmed by double ELISA. 
3.  HIV positive patients never having 
cardiovascular complaints or records prior to 
diagnosis of HIV. 
 
Exclusion criteria 
1. Subjects unwilling to participate in the study 
2. Pregnant women 
3. Subjects  who are using Cholesterol lowering 
drug 
Consent and confidentiality: HIV testing for the 
purpose of identification of cases and controls was 
undertaken after pre – test counseling and informed 
consent. The confidentiality of the test result was 
strictly maintained. The test result, name of the 
individual and address was kept in secrecy.  
 
Study measures 
 
ELISA 
ELISA was the most commonly performed screening 
test. It is easy to perform, adaptable to large number of 
samples, is sensitive, specific and cost effective. All 
ELISA consist of either antigen or antibody (depending 
upon the principle) attached on a solid phase (matrix or 
support) and, incorporate a conjugate and substrate 
detection system. Viral antigens may be whole virus 
lysates, recombinant or synthetic peptides. The matrix 
can be “wells” or “strips” of a micro plate, plastic 
beeds or nitrocellulose paper. Conjugates are most 
often antibodies (IgG, sometimes IgM and IgA also) 
coupled to enzymes (alkaline phosphatase or horse 
radish peroxidase), flourochromes or other reagents 
that will subsequently bring about a reaction that can 
be visualized. In case of enzyme conjugates the signal 
generated is a color reaction. The substrates used are 4 
– nitrophenoyl phosphate for alkaline phosphatase and 
o – phynxylencdiaminedihydrochloride(OPD) and 
TMB for horse radish peroxidase, which produce color 
on being acted upon by the respective enzymes and the 
color can be either detected visually or measured on a 
ELISA reader as OD values.  In doubtful cases 
confirmatory Western Blot analysis was performed. 
 
Fasting lipid profile 
Serum concentration of total cholesterol, HDL 
cholesterol , LDL cholesterol and triglycerides were 
estimated by semiautoanalyser of BAYER company , 
using separate kit for each of them in the biochemistry 
department of Rajendra Institute Of Medical Sciences. 
• For Triglyceride : 1 ml of blood was centrifuged. 
Then 10 microlitreserum was mixed with 1 ml 
reagent. 
• For total cholesterol: 10 microlitre serum taken 
after centrifugation and mixed with 1 ml of 
cholesterol reagent. 
• For HDL estimation :  0.2 ml serum is mixed with 
HDL reagent (A) 0.2 ml to precipitate serum 
which is centrifuged at 2000 rpm for 10 minutes. 
20 microlitre of the supernatant is again mixed 
with 1 ml HDL reagent (B). All the three samples 
were incubated at 37 degree Celsius for five 
minutes. Then the reading was taken. 
*LDL Cholesterol was calculated using the 
FRIEDWALD formula, i.e. LDL cholesterol = Total 
cholesterol – ( HDL cholesterol +TG/5 ) 
 
Cut off values for diagnosis 
 
1. Case definiton of aids  
2. Two positive tests for HIV infection (by ERS) 
method and  
3. Any one of the following criteria :  
a) Significant weight loss (> 10% of the body 
weight) within last one month / cachexia ( not 
known to be due to a condition other than HIV 
infection.) and Chronic diarrhea ( intermittent 
or continuous ) > one month             duration  
or prolonged fever (intermittent or 
continuous) > one month duration.  
b) Tuberculosis: Extensive pulmonary 
tuberculosis, disseminated , military , extra – 
pulmonary. 
c) Neurological impairment preventing 
independent daily   activities, not known to be 
due to a condition unrelated to HIV infection ( 
e.g. trauma). 
d) Candidiasis of the esophagus (diagnosable by 
oral   candidiasis     with odynophagia). 
e) Clinically diagnosed life threatening, or 
recurrent episodes of pneumonia, with or 
without etiological confirmation. 
f) Kaposi sarcoma. 
g) Other conditions  
• Cryptococcal meningitis 
• Neuro toxoplasmosis 
• CMV retinitis 
• Pencilliummarneffei 
• Recurrent Herpes Zoster and multi – 
dermatomal 
• Disseminated molluscum 
2. Hypercholesterolemia  
Total cholesterol more than 200 mg/dl. 
3.Hypertriglyceridemia  
Estimated triglycerides greater than 150 mg/dl. 
4.Low HDL cholesterol  
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HDL cholesterol less than 40 mg/dl. 
5.Elevated LDL Cholesterol  
LDL cholesterol greater than 130 mg/dl. 
 
 
Observations 
 
The study was conducted from June 2006 to October 
2007.A total number of 51 cases and 51 controls were 
included in the study. 
 
 
Figure 1:Age pattern of the cases 
Age pattern of the cases   
  
Cases were mostly in the 30-40 year age group. Most 
of these patients had a history of acquiring the infection 
at an age of 17-25 years. Our youngest patient was 20 
years and a 55 year old male was the oldest one[Figure 
1]. 
 
 
Figure 2: Sex ratio of the cases 
Sex distribution of the cases  
 
73% cases were males/All women were married to 
spouse carrying the infection [Figure 2].This is 
important in its epidemiological aspect that most of 
them were having children and the infection was 
transmitted directly to them. It also shows that an 
alarming number of children will be left without their 
parents, very early in their childhood. 
 
 
Figure 3: Source of HIV in cases 
Sources of HIV in cases 
 
The pie diagram shows that most of the patients who 
came to us gave a history of working in Mumbai, some 
patients had a history of travel to multiple cities[Figure 
3]. Another important observation was that all of the 
women were infected with HIV got their infection from 
their infected spouses. 
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Figure 4:CD4 count in the patients studied 
CD4 count in the patients studied 
 
We had the maximum number of patients in the CD4 
count < 50 cells/mm3 range [Figure 4]. This shows the 
level of ignorance and the delayed access of these 
patients to a health care provider. 
 
 
Figure 5:A comparison of the lipid profile of cases and controls 
 
Comparison of lipid profile of Cases and Controls 
 
We can see the markedly distorted lipid profile in the  
HIV infected patients by looking at the bar diagram. 
There is a marked decrease in the Total Cholesterol, 
HDL cholesterol, LDL Cholesterol without any 
significant changes in the level of Triglycerides. The 
atherogenic milieu created is appreciated by seeing the 
markedly raised TC/HDL ratio[ Figure 5]. 
 
 
Figure 6: Dyslipedemia pattern in HIV infected patients 
 
Dyslipedemia pattern in HIV infected patients 
The HIV infected patients were again classified into 
two groups- Those with CD4 count > 200  and those 
with CD4 Count< 200.Observation was that HIV 
patients having CD4 count  < 200  were having more 
severe derangements in ther lipid profile [Figure 6]. 
 
 
 
Discussion 
 
The study was conducted from June 2006 to October 
2007. During this one and half year period 51 cases and 
51 controls were enrolled for the study. The mean age 
of the cases was 32 years (max. – 55yrs; min. – 20yrs). 
The average age of the patients was 37 years in the 
study conducted by Himelman et al[1]. In the study 
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done by Hernandez et al the average age was 33.2 
years[2]. The mean age of the controls was 34 years. 
73% were males in the case group as well as the 
control group. In the study done by Minardi et al 78 % 
of the HIV patients were males[3]. In the study done by 
Hernandez et al 73 % patients were males[2]. In the 
study by Himelman et al 93 % were males[1]. In our 
study 28 % of patients were having a CD4 count < 50 
cells/mm3 , 8 % of patients were having a CD4 count 
between 50 and 100 cells/mm3 , 24 % of patients were 
in the range of 100 – 200, 20 % of patients were having 
a CD4 count between 200 and 500. Only 20 % of 
patients were having a CD4 count greater than500 
cells/mm3. A total of 60 % of patients were having a 
CD4 count < 200 cells/mm3. The mean CD4 count in 
our study was 240 cells/mm3, much less than that of the 
cases studied in the western population. The mean CD4 
count in the study done by Barbaro et al was 670 cells / 
mm3[4]. The mean CD4 count in the study done by 
Mittal et al was 426 cells/mm3[5]. Although the 
purpose of the study was to look into the lipid profile 
abnormalities in the subjects enrolled for the study, a 
detailed in look into the epidemiological aspects was 
also done. The socioeconomic factors having a role in 
the case detection and treatment were taken into 
account. At the time of recruitment most of the patients 
were having some associated complaints and all of the 
controls were asymptomatic.A complete cardiovascular  
evaluation was done including clinical examination, 
electrocardiogram, fasting lipid profile and 
echocardiogram on all cases as well as controls. The 
findings of examination as well as the results of lab 
findings were entered on the proforma which was 
prepared. 
Statistical tests were done on the results obtained from 
cases and controls. The analysis revealed that  
• Total Cholesterol was significantly lower (p < 
0.001) for the case (mean = 130.55) compared to 
the control group (mean = 156.41). An increase in 
the total cholesterol was found in the study done 
by Periard et al[6]. But this study was done in 
patients taking  HAART. 
• HDL Cholesterol was significantly lower (p < 
0.001) for the case (mean = 31.08) compared to 
the control group (mean = 42.37). This has been 
reported in the study by Zahedi et al and 
Krishnaswamy et al[7-8]. 
• LDL Cholesterol was significantly lower (p = 
0.014) for the case (mean = 70.41) compared to 
the control group (mean = 83.06). An elevation in 
LDL cholesterol was reported in the study by 
Cameron et al, but all the patients were on 
therapy with protease inhibitors[9]. 
• TC/HDL was significantly higher (p < 0.001) for 
the HIV positive patients (mean = 4.56) 
compared to the control group (mean = 3.76). 
• The difference between those tested positive 
(mean = 144.88) and the control group (mean = 
141.04) was not significant (p = 0.725) in the 
case of triglyceride. This is similar to that in the 
study done by Periard et al[6]. 
 
Conclusions 
 
HIV positive patients with a CD4 count more than 200 
were having few abnormalities in the lipid profile as 
well as echocardiography. Patients with a CD4 count 
less than 200 were having marked abnormalities in the 
lipid profile, electrocardiograms and echocardiography. 
Atherogenic dyslipidemia was present in high 
frequency in patients with a low CD4 count. There was 
a decrease in total cholesterol, HDL cholesterol and  
LDL cholesterol. But there was no significant change 
in the level of triglyceride. The level of total 
cholesterol – HDL ratio was considerably increased in 
the HIV positive patients. 
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